| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/25/2010 | WO2009149397A3 Respiratory syncytial virus renders dendritic cells tolerogenic |
| 03/25/2010 | WO2009145814A3 Pyrimidines and pyridines useful as inhibitors of protein kinases |
| 03/25/2010 | WO2009111083A3 In vivo temporal control of activ at able matrix- degrading enzymes |
| 03/25/2010 | US20100076030 Methods of treating rheumatoid arthritis |
| 03/25/2010 | US20100075904 Carbon nanotube composite scaffolds for bone tissue engineering |
| 03/25/2010 | US20100075900 Use of Nutritional Compositions for Preventing Disorders |
| 03/25/2010 | US20100075893 Preparation of a pharmaceutical composition for increasing bone mineral density |
| 03/25/2010 | US20100074970 Method and composition for preventing and healing osteonecrosis of the jaw |
| 03/25/2010 | US20100074949 Pharmaceutical composition and administration thereof |
| 03/25/2010 | US20100074939 Harmine compounds for promoting bone growth |
| 03/25/2010 | US20100074935 Recombinant lubricin molecules and uses thereof |
| 03/25/2010 | US20100074898 Amino nicotinic and isonicotinic acid derivatives as dhodh inhibitors |
| 03/25/2010 | US20100074876 Calcium phosphate delivery vehicles for osteoinductive proteins |
| 03/25/2010 | CA2738018A1 Carboxyethylated cyclodextrin polysulfates useful as medicaments |
| 03/25/2010 | CA2737738A1 Heterocyclic carboxamide compounds |
| 03/25/2010 | CA2736980A1 Aryl-phenyl-sulfonamide-phenylene compounds and their use |
| 03/24/2010 | EP2166095A2 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes in endothelial cells |
| 03/24/2010 | EP2166087A2 FAD4, FAD5, FAD5-2 et FAD6, fatty acid desaturase family members and uses thereof |
| 03/24/2010 | EP2166010A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 03/24/2010 | EP2166009A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors |
| 03/24/2010 | EP2166008A1 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 03/24/2010 | EP2165716A1 Novel bone mass increasing agent |
| 03/24/2010 | EP2165605A1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation |
| 03/24/2010 | EP2164827A2 Novel derivatives of 3-phenyl acrylic acid activating ppar-type receptors, method for preparing same and use thereof in cosmetic or pharmaceutical compositions |
| 03/24/2010 | EP2046791B1 Urea derivatives of tropane, their preparation and their therapeutic application |
| 03/24/2010 | EP1389110B1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/24/2010 | EP1180938B1 Agents, compositions and methods utilizing the same useful in treating or preventing alzheimer disease |
| 03/24/2010 | EP1075496B1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
| 03/24/2010 | CN101680887A Method of determining risk of scoliosis |
| 03/24/2010 | CN101679421A New imidazo[ 4,5-b]pyridine-7-carboxamides 704 |
| 03/24/2010 | CN101679355A benzimidazole cannabinoid agonists |
| 03/24/2010 | CN101679327A Substituted phenoxy aminothiazolones as estrogen related receptor-alpha modulators |
| 03/24/2010 | CN101679322A Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators |
| 03/24/2010 | CN101678077A Novel antiphlogistic-analgesic agent |
| 03/24/2010 | CN101678022A 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors |
| 03/24/2010 | CN101678014A 杂环激酶调节剂 Heterocycle kinase modulators |
| 03/24/2010 | CN101677983A Composition useful for the prevention of adverse effect due to the use of ppar-gamma agonists |
| 03/24/2010 | CN101677978A Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor |
| 03/24/2010 | CN101677606A Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food |
| 03/24/2010 | CN101676401A Scorpion peptide and preparation method |
| 03/24/2010 | CN101676286A Azaindoles useful as inhibitors of JAK and other protein kinases |
| 03/24/2010 | CN101675959A Limaigubang capsule |
| 03/24/2010 | CN101675927A therapeutic molecules and methods-1 |
| 03/24/2010 | CN101675920A An externally-applied patch |
| 03/24/2010 | CN100595211C Angiopoietin-2 specific binding agents |
| 03/24/2010 | CN100594930C Medicinal composition using anterior pituitary adrenal cortical extract as main component, and its preparation method and use |
| 03/24/2010 | CN100594928C Curcuma extract and its prepn process, medicine composition and use |
| 03/24/2010 | CN100594919C Compositions containing an active fraction isolated from lycium barbarum and methods of using the same |
| 03/24/2010 | CN100594918C Compound Chinese medicinal oral preparation for treating osteoporosis and preparation method thererof |
| 03/24/2010 | CN100594897C Cannabinoid liquid formulations for mucosal amdinistration |
| 03/23/2010 | US7683164 Nucleic acid derivatives |
| 03/23/2010 | US7683094 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 03/23/2010 | US7683078 Neuronal disorders, autoimmune diseases, cancer, cardiovascular diseases; such as 4-Chloro-N-{5-[1-(4-trifluoromethyl-benzyl)-piperidin-3-ylsulfamoyl]-25 thiophen-2-ylmethyl)-benzamide |
| 03/23/2010 | US7683074 Antiinflammatory agents; antiallergens; neurodegrative disease ; autoimmune disease; antiarthritic agents |
| 03/23/2010 | US7683061 rheumatoid arthritis, systemic lupus erythematosus (SLE), idiopathic (immune) thrombocytopenia (ITP), glomerulonephritis and vasculitis; reduced drug toxicity |
| 03/23/2010 | CA2389767C Quinazoline derivatives as vegf inhibitors |
| 03/23/2010 | CA2377278C Prodrugs of carbamate inhibitors of impdh |
| 03/23/2010 | CA2346869C Phospholipid derivatives of non-steroidal anti-inflammatory drugs |
| 03/23/2010 | CA2309639C Small peptides and methods for treatment of asthma and inflammation |
| 03/18/2010 | WO2010030244A1 A heparan sulphate which binds bmp2 |
| 03/18/2010 | WO2010030241A1 Therapeutic bone growth and regeneration |
| 03/18/2010 | WO2010029938A1 Novel crystal forms of 4-(2-aminopyridin-4-yl)-3-(4–fluoro- phenyl)-1-(1,4,5,6-tetrahydro-6-oxopyridazin-3-yl)-1h-pyra-zole methanesulfonate and process for production of same |
| 03/18/2010 | WO2010029364A1 Compounds |
| 03/18/2010 | WO2010029335A1 Method for delivering a pharmaceutical composition to patient in need thereof |
| 03/18/2010 | WO2010028981A1 New benzimidazole derivatives |
| 03/18/2010 | WO2010028596A1 The pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof |
| 03/18/2010 | WO2010028432A1 Protocols for treating bone disorders |
| 03/18/2010 | WO2010010288A3 Alkyl thiazole carbamate derivatives, preparation thereof, and use thereof as faah enzyme inhibitors |
| 03/18/2010 | WO2010003601A8 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use |
| 03/18/2010 | WO2009115525A3 Preparation of a pharmaceutical composition for increasing bone mineral density |
| 03/18/2010 | WO2009033715A3 Use of slit, nephrin, ephrin or semaphorin for treatment of cartilage diseases |
| 03/18/2010 | US20100071079 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l |
| 03/18/2010 | US20100069501 Pharmaceutical Composition Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol and Paracetamol |
| 03/18/2010 | US20100069478 Isoflavone derivatives and uses thereof |
| 03/18/2010 | US20100069466 Compositions and Methods for the Systemic Treatment of Arthritis |
| 03/18/2010 | US20100069459 Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid magnesium |
| 03/18/2010 | US20100069422 Methods and compositions for promoting bone and joint health |
| 03/18/2010 | US20100069404 TETRAHYDROCYCLOPENTA[b] INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS |
| 03/18/2010 | US20100069396 4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines |
| 03/18/2010 | US20100069365 Diazepane-acetamide derivatives as selective 11B-HSD1 inhibitors |
| 03/18/2010 | US20100069358 Use of 7-azaindoles in the inhibition of c-jun n-terminal kinase |
| 03/18/2010 | US20100069354 7-azaindole derivatives and their use in the inhibition of c-jun n-terminal kinase |
| 03/18/2010 | US20100069330 Pharmaceutical Compositions and Methods for Preparing and Using Lipophilic Organosulfur Cell Proliferation Inhibitors |
| 03/18/2010 | US20100069303 Methods of treating bone disease using vascular endothelial growth factor fusion constructs |
| 03/18/2010 | US20100068305 Mixture for use as a wound dressing |
| 03/18/2010 | US20100068281 Methods and compositions for tissue regeneration |
| 03/18/2010 | US20100068273 Pharmaceutical formulation, its use, and method for its manufacture |
| 03/18/2010 | US20100068241 Reconstituted mineralized cartilage tissue |
| 03/18/2010 | US20100068239 Osteogenic Device for Inducing Bone Formation in Clinical Contexts |
| 03/18/2010 | US20100068201 Compositions and methods for the systemic treatment of arthritis |
| 03/18/2010 | US20100068177 Methods of organ regeneration |
| 03/18/2010 | US20100068171 Injectable bone/polymer composite bone void fillers |
| 03/18/2010 | US20100068168 Thermal responsive polymer siloxanes, compositions, and method and applications related thereto |
| 03/18/2010 | CA2736554A1 Novel crystal forms of 4-(2-aminopyridin-4-yl)-3-(4-fluorophenyl)-1-(1,4,5,6-tetrahydro-6-oxopyridazin-3-yl)-1h-pyrazole methanesulfonate and methods for their preparation |
| 03/18/2010 | CA2736547A1 Method for delivering a pharmaceutical composition to patient in need thereof |
| 03/18/2010 | CA2734309A1 Preparation and usage of a pharmaceutical composition containing ferulic acid and matrine compounds |
| 03/18/2010 | CA2734034A1 New benzimidazole derivatives |
| 03/17/2010 | EP2163557A1 Function-selective vitamin d receptor agonist |
| 03/17/2010 | EP2163241A1 Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| 03/17/2010 | EP2162531A1 Method and means for culturing osteoblastic cells |